Cargando…

Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment

OBJECTIVE: This study aimed to evaluate the total antioxidant activity (TAA) in patients with major depressive disorder (MDD) and the effect of antidepressants on TAA using a novel potentiometric method. METHODS: Twenty-eight patients with MDD and thirty-one healthy controls were enrolled in this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baek, Song-Eun, Lee, Gyoung-Ja, Rhee, Chang-Kyu, Rho, Dae-Young, Kim, Do-Hoon, Huh, Sun, Lee, Sang-Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823199/ https://www.ncbi.nlm.nih.gov/pubmed/27081384 http://dx.doi.org/10.4306/pi.2016.13.2.222

Ejemplares similares

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

The Effects of Antidepressant Treatment on Serum Cytokines and Nutritional Status in Hemodialysis Patients
por: Lee, Sang-Kyu, et al.
Publicado: (2004)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

PS78. Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder
por: Cho, Se Hoon, et al.
Publicado: (2016)

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
por: Behr, Guilherme A., et al.
Publicado: (2012)

Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants
por: Martín-Hernández, David, et al.
Publicado: (2018)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
por: Cheon, Eun-Jin, et al.
Publicado: (2016)

The epidemiology of antidepressant use in South Korea: Does short-term antidepressant use affect the relapse and recurrence of depressive episodes?
por: Kim, Min Ji, et al.
Publicado: (2019)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

An electroencephalographic signature predicts antidepressant response in major depression
por: Wu, Wei, et al.
Publicado: (2020)

Antioxidative Activity after Rosuvastatin Treatment in Patients with Stable Ischemic Heart Disease and Decreased High Density Lipoprotein Cholesterol
por: Park, Do-Sim, et al.
Publicado: (2016)

Increase in the prescription rate of antidepressants after the Sewol Ferry disaster in Ansan, South Korea
por: Han, Kyu-Man, et al.
Publicado: (2017)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response
por: Hervé, Mylène, et al.
Publicado: (2017)

The effect of antidepressant treatment on white matter integrity in Major Depression
por: Tourjman, S., et al.
Publicado: (2022)

Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder
por: Kim, Jae-Won, et al.
Publicado: (2013)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
por: Lee, K.H., et al.
Publicado: (2022)

The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men
por: Rauma, P.H., et al.
Publicado: (2015)

Prediction of Antidepressant Treatment Outcome Using Event-Related Potential in Patients with Major Depressive Disorder
por: Lee, Hyun Seo, et al.
Publicado: (2020)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
por: Choi, Hyebin, et al.
Publicado: (2021)

Magnesium Sulfate Treatment During Total Knee Arthroplasty Decreases Postoperative Urinary Retention: A Retrospective Propensity Score-Matched Analysis
por: Park, Jin-Woo, et al.
Publicado: (2020)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Noncontinuous use of antidepressant in adults with major depressive disorders – a retrospective cohort study
por: Yau, Wai-Yin, et al.
Publicado: (2014)

Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses
por: Lee, Jiyeong, et al.
Publicado: (2015)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

Precisely Determining Ultralow level UO(2)(2+) in Natural Water with Plasmonic Nanowire Interstice Sensor
por: Gwak, Raekeun, et al.
Publicado: (2016)

The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy
por: Carta, Mauro Giovanni, et al.
Publicado: (2010)

Antidepressant Treatment Normalizes White Matter Volume in Patients with Major Depression
por: Zeng, Ling-Li, et al.
Publicado: (2012)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Brain arousal regulation as response predictor for antidepressant therapy in major depression
por: Schmidt, Frank M., et al.
Publicado: (2017)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

Association between ABCB1 Polymorphisms and Antidepressant Treatment Response in Taiwanese Major Depressive Patients
por: Chang, Hui Hua, et al.
Publicado: (2015)

Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
por: Lee, Jeong-Ok, et al.
Publicado: (2018)

Depression, antidepressants and driving safety
por: Hill, Linda L., et al.
Publicado: (2017)

PS162. Genetic role of CSNK1E on circadian and childhood characteristics of the patients with major depressive disorder
por: Joo, Eun-Jeong, et al.
Publicado: (2016)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
por: Moon, Seok Woo, et al.
Publicado: (2023)

The comparative effectiveness of antidepressants for youths with major depressive disorder: a nationwide population-based study in Taiwan
por: Lee, Sheng-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t2f65ijb2nsldbqlsr9a4br9rd